Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure
- 1 October 1994
- journal article
- clinical trial
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 8 (5) , 685-692
- https://doi.org/10.1007/bf00877115
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure studyThe American Journal of Cardiology, 1991
- The Effects of ACE Inhibitors on Exercise Capacity in the Treatment of Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionThe American Journal of Cardiology, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981
- Determination of norepinephrine apparent release rate and clearance in humansLife Sciences, 1979
- Plasma norepinephrine in congestive heart failurePublished by Elsevier ,1978
- Renin relationships in congestive cardiac failure, treated and untreatedAmerican Heart Journal, 1970